Goldman Drops Sell on Ibotta After 45% Rally

Goldman Sachs has abandoned its Sell rating on IBTA, upgrading to Neutral and raising its price target 66% from $35 to $58. Analyst Eric Sheridan made the call on 4 November, the same day the stock was trading at $60.35, already above the new target after a 45% gain over the past month.

The upgrade marks a significant reversal. Sheridan had maintained a Sell rating through August, raising his target only to $32 at the time. The move follows a cluster of target increases from other desks after Ibotta reported earnings on 2 November, with the stock jumping 24% on the day.

Analyst Consensus Still Catching Up

Wells Fargo and Evercore ISI both raised targets on 3 November, to $49 and $58 respectively, while maintaining Equal-Weight and In-Line ratings. Needham, the most constructive desk on the register, lifted its Buy target to $65 from $45. The consensus remains a Hold across seven analysts, with a mean price target of $45.43 as of 3 November, well below where the stock is trading.

That gap between consensus target and market price tells its own story. The stock has moved faster than analyst models, and the Goldman upgrade formalises what the market already decided.

Short Sellers Stepping Back

Short interest has fallen to 11.7% of the free float, down from roughly 14.4% at the start of October. The pace of retreat accelerated in the week before earnings, dropping around 18% in seven days. With the float still carrying an 11.7% short position, some of that overhang remains.

Borrow conditions have tightened as shorts unwind. Availability stood at 50.3% on 3 November, down sharply from above 100% in mid-October. For context, the 52-week low in availability reached 11.0%, so the lending market is tighter than normal but not at an extreme. The cost to borrow was 0.96% as of 3 November, up around 9% over the past month.

Options positioning has also shifted. The put-call ratio hit 1.28 on 3 November, a 52-week high and well above the 20-day mean of 0.74, suggesting fresh demand for downside protection even as the stock rallied.

Data Summary

• Goldman Sachs upgrades IBTA to Neutral from Sell; price target raised to $58 from $35
• Stock at $60.35, up 45% over one month and 24% on earnings day (2 November)
• Short interest: 11.7% of free float, down from roughly 14.4% at October's start
• Borrow availability: 50.3%, down from above 100% in mid-October
• Cost to borrow: 0.96%, up 9% over one month
• Put-call ratio: 1.28, a 52-week high; 20-day mean was 0.74